Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carine Dufauret-Lombard

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Presse Medicale (Paris, France : 1983)|December 6, 2007
[What are the cardiovascular complications of the analgesics and glucocorticoids?]Carine Dufauret-Lombard, Philippe Bertin
Joint Bone Spine|January 26, 2010
Ultrasonography in chondrocalcinosisCarine Dufauret-Lombard, Pascale Vergne-Salle, Anne Simon, et al.
Bulletin De L'Academie Nationale De Medecine|January 2, 2007
[Contribution of sacroiliac magnetic resonance imaging (MRI) to the evaluation of infliximab efficacy in spondyloarthropathy (a prospective study of 34 patients)]Richard Treves, Carine Dufauret-Lombard, Pascale Vergne-Salle, et al.
European Journal of Pain (London, England)|November 2, 2010
A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgiaPascale Vergne-Salle, Carine Dufauret-Lombard, Christine Bonnet, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Presse Medicale (Paris, France : 1983)|December 6, 2007
[What are the cardiovascular complications of the analgesics and glucocorticoids?]Carine Dufauret-Lombard, Philippe Bertin
Joint Bone Spine|January 26, 2010
Ultrasonography in chondrocalcinosisCarine Dufauret-Lombard, Pascale Vergne-Salle, Anne Simon, et al.
Bulletin De L'Academie Nationale De Medecine|January 2, 2007
[Contribution of sacroiliac magnetic resonance imaging (MRI) to the evaluation of infliximab efficacy in spondyloarthropathy (a prospective study of 34 patients)]Richard Treves, Carine Dufauret-Lombard, Pascale Vergne-Salle, et al.
European Journal of Pain (London, England)|November 2, 2010
A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgiaPascale Vergne-Salle, Carine Dufauret-Lombard, Christine Bonnet, et al.
Pageof 1